Addus HomeCare Crecimiento futuro

Future controles de criterios 2/6

Addus HomeCare se prevé un crecimiento anual de los beneficios y los ingresos de 12.1% y 6.3% respectivamente. Se prevé que el BPA sea de grow en 12% al año. Se prevé que la rentabilidad de los fondos propios sea de 11% en 3 años.

Información clave

11.7%

Tasa de crecimiento de los beneficios

11.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	23.4%
Tasa de crecimiento de los ingresos	6.3%
Rentabilidad financiera futura	11.0%
Cobertura de analistas	Good
Última actualización	26 Mar 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Previsiones de crecimiento de beneficios e ingresos

DB:A41 - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	1,285	90	105	N/A	2
12/31/2025	1,206	80	92	105	7
12/31/2024	1,144	72	80	87	7
12/31/2023	1,059	63	103	112	N/A
9/30/2023	1,029	58	97	106	N/A
6/30/2023	999	54	94	103	N/A
3/31/2023	976	50	110	118	N/A
12/31/2022	951	46	97	105	N/A
9/30/2022	929	44	102	106	N/A
6/30/2022	905	44	101	105	N/A
3/31/2022	886	45	59	64	N/A
12/31/2021	864	45	35	39	N/A
9/30/2021	836	41	46	50	N/A
6/30/2021	813	38	51	55	N/A
3/31/2021	780	33	65	71	N/A
12/31/2020	765	33	103	109	N/A
9/30/2020	761	35	70	77	N/A
6/30/2020	736	32	60	67	N/A
3/31/2020	701	30	29	36	N/A
12/31/2019	649	26	7	12	N/A
9/30/2019	594	19	12	17	N/A
6/30/2019	563	17	3	9	N/A
3/31/2019	545	16	10	16	N/A
12/31/2018	517	16	28	33	N/A
9/30/2018	488	16	31	35	N/A
6/30/2018	457	16	81	84	N/A
3/31/2018	427	14	55	57	N/A
12/31/2017	416	12	49	53	N/A
9/30/2017	409	18	N/A	11	N/A
6/30/2017	404	16	N/A	6	N/A
3/31/2017	402	16	N/A	15	N/A
12/31/2016	394	12	N/A	-1	N/A
9/30/2016	377	8	N/A	26	N/A
6/30/2016	359	9	N/A	-49	N/A
3/31/2016	346	9	N/A	-1	N/A
12/31/2015	333	11	N/A	4	N/A
9/30/2015	335	12	N/A	8	N/A
6/30/2015	332	12	N/A	27	N/A
3/31/2015	323	12	N/A	3	N/A
12/31/2014	313	12	N/A	7	N/A
9/30/2014	300	11	N/A	10	N/A
6/30/2014	286	11	N/A	8	N/A
3/31/2014	275	11	N/A	17	N/A
12/31/2013	266	11	N/A	27	N/A
9/30/2013	260	12	N/A	31	N/A
6/30/2013	254	11	N/A	44	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. tasa de ahorro: A41(13.4% al año) es superior a la tasa de ahorro (0.5%).

Beneficios frente mercado: A41Se prevé que los beneficios de la empresa (11.5% al año) crezcan menos que el mercado German (13.7% al año).

Beneficios de alto crecimiento: A41Se prevé que los beneficios de la empresa crezcan, pero no significativamente.

Ingresos vs. Mercado: A41Se prevé que los ingresos de la empresa (7% al año) crezcan más deprisa que los del mercado German (4.6% al año).

Ingresos de alto crecimiento: A41Se prevé que los ingresos de la empresa (7% al año) crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Futura rentabilidad financiera (ROE): A41Se prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (11%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Addus HomeCare Crecimiento futuro

Future controles de criterios 2/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Full year 2023 earnings released: EPS: US$3.83 (vs US$2.90 in FY 2022)

Addus HomeCare Corporation to Report Q4, 2023 Results on Feb 26, 2024

Insufficient new directors

Third quarter 2023 earnings released: EPS: US$0.95 (vs US$0.73 in 3Q 2022)

Addus HomeCare Corporation to Report Q3, 2023 Results on Oct 30, 2023

CEO & Chairman of the Board recently sold €2.1m worth of stock

Now 21% undervalued

Addus HomeCare Corporation completed the acquisition of Tennessee Quality Care.

Second quarter 2023 earnings released: EPS: US$0.91 (vs US$0.71 in 2Q 2022)

Addus HomeCare Corporation to Report Q2, 2023 Results on Jul 31, 2023

Addus HomeCare Corporation entered into a definitive agreement to acquire Tennessee Quality Care.

First quarter 2023 earnings released: EPS: US$0.78 (vs US$0.54 in 1Q 2022)

Investor sentiment deteriorates as stock falls 28%

Now 23% undervalued after recent price drop

Insider recently sold €72k worth of stock

Full year 2022 earnings released: EPS: US$2.84 (vs US$2.87 in FY 2021)

Addus HomeCare Corporation to Report Q4, 2022 Results on Feb 27, 2023

Insider recently sold €83k worth of stock

CEO & Chairman of the Board recently sold €1.4m worth of stock

CFO, Executive VP recently sold €410k worth of stock

Third quarter 2022 earnings released: EPS: US$0.71 (vs US$0.73 in 3Q 2021)

Addus HomeCare Corporation to Report Q3, 2022 Results on Oct 31, 2022

Addus HomeCare Corporation (NasdaqGS:ADUS) acquired Apple Home Healthcare, LTD.

Addus HomeCare Corporation (NasdaqGS:ADUS) acquired Apple Home Healthcare, LTD.

Addus HomeCare Corporation Announces Demise of Steven L. Geringer, Director

Independent Director recently sold €103k worth of stock

Executive VP & Chief Legal Officer recently sold €147k worth of stock

Second quarter 2022 earnings released: EPS: US$0.70 (vs US$0.74 in 2Q 2021)

Addus HomeCare Corporation to Report Q2, 2022 Results on Aug 01, 2022

Investor sentiment improved over the past week

Insider recently sold €106k worth of stock

First quarter 2022 earnings released: EPS: US$0.53 (vs US$0.57 in 1Q 2021)

Addus HomeCare Corporation Names Cliff Blessing as Executive Vice President and Chief Development Officer

Addus HomeCare Corporation to Report Q1, 2022 Results on May 03, 2022

Addus HomeCare Corporation Promotes Monica Raines to Executive Vice President, Chief Compliance and Quality Officer

Addus HomeCare Corporation Promotes Monica Raines to Executive Vice President, Chief Compliance and Quality Officer

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Addus HomeCare Corporation to Report Q4, 2021 Results on Feb 24, 2022

Addus HomeCare Corporation (NasdaqGS:ADUS) completed the acquisition of Substantially All the Assets of Journeycare, Inc.

Third quarter 2021 earnings released: EPS US$0.72 (vs US$0.58 in 3Q 2020)

Investor sentiment improved over the past week

Insider recently sold €53k worth of stock

Second quarter 2021 earnings released: EPS US$0.72 (vs US$0.44 in 2Q 2020)

Addus HomeCare Corporation (NasdaqGS:ADUS) agreed to acquire Armada Skilled Home of New Mexico, LLC/Armada Hospice of New Mexico, LLC/Armada Hospice of Santa Fe for $29 million.

Executive VP & Chief Human Resource Officer Laurie Manning has left the company

CFO, Executive VP recently sold €501k worth of stock

First quarter 2021 earnings released: EPS US$0.55 (vs US$0.56 in 1Q 2020)

Addus HomeCare Reaches Post-Acute Care Navigation Agreement With Presbyterian Health Plan In New Mexico

New 90-day low: €82.50

Full year 2020 earnings released: EPS US$2.08 (vs US$1.87 in FY 2019)

Revenue misses expectations

Addus HomeCare Corporation to Report Q4, 2020 Results on Feb 25, 2021

New 90-day high: €103

Addus HomeCare Names Veronica Hill-Milbourne And Esteban López, M.D. To Board Of Directors

New 90-day high: €97.50

Addus HomeCare Corporation (NasdaqGS:ADUS) completed the acquisition of Queen City Hospice, LLC from Stonehenge Opportunity Fund IV, LP managed by Stonehenge Partners, Inc.

Insider recently sold €61k worth of stock

Addus HomeCare Corporation (NasdaqGS:ADUS) signed a definitive agreement to acquire Queen City Hospice, LLC for approximately $190 million.

New 90-day high: €97.00

Third quarter 2020 earnings released: EPS US$0.57

Revenue beats expectations

Addus HomeCare Corporation (NasdaqGS:ADUS) acquired County HomeMakers, Inc.

Addus HomeCare Corporation to Report Q3, 2020 Results on Nov 02, 2020

Three Oaks Hospice, Inc. acquired Hospice Partners of Kansas, LLC from Addus HomeCare Corporation (NasdaqGS:ADUS).

New 90-day low - €74.00

CEO, President & Director recently sold €1.1m worth of stock

New 90-day high - €89.00

First half earnings released

Addus HomeCare Corporation to Report Q2, 2020 Results on Aug 10, 2020

Addus HomeCare Corporation (NasdaqGS:ADUS) acquired A Plus Health Care, Inc.

Addus HomeCare Corporation(NasdaqGS:ADUS) dropped from Russell Microcap Growth Index

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura